User Visitor Login
/images/graph_sv_i.gif
English only
EPFL > FSV > BBP > Channelpedia
Ion channels
References
Reports
SEARCH IN WIKI
Logged in as a Visitor.

Pain Channelopathies.

Roman Cregg, Aliakmal Momin, François Rugiero, John N Wood, Jing Zhao

, 2010 Feb 8 , ,

Pain remains a major clinical challenge, severely afflicting around six per cent of the population at any one time. Channelopathies that underlie monogenic human pain syndromes are of great clinical relevance, as cell surface ion channels are tractable drug targets. The recent discovery that loss of function mutations in the sodium channel Nav1.7 underlies a recessive pain free state in otherwise normal people is particularly significant. Deletion of channel-encoding genes in mice has also provided insights into mammalian pain mechanisms. Ion channels expressed by immune system cells (e.g. P2X7) have been shown to play a pivotal role in changing pain thresholds, whilst channels involved in sensory transduction (e.g. TRPV1), the regulation of neuronal excitability (Potassium channels), action potential propagation (Sodium channels) and neurotransmitter release (Calcium channels) have all been shown to be potentially selective analgesic drug targets in some animal pain models. Migraine and visceral pain have also been associated with voltage-gated ion channel mutations. Insights into such channelopathies thus provide us with a number of potential targets to control pain.

http://www.ncbi.nlm.nih.gov/pubmed/20142270